Husseini K. Manji
ScholarGPS® ID: 19790804660879
Affiliation History
Field
Life Sciences
Discipline
Neurosciences
Metrics Summary
Publication Count
399
Predicted Citations
54,145
Predicted h-index
128
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
Non-canonical pathways in the pathophysiology and therapeutics of bipolar disorder (journal article) Frontiers in Neuroscience, volume 17 (2023). |
The American Journal of Geriatric Psychiatry, volume 30, issue 5, pages 541-556 (2022). |
Immune targets for therapeutic development in depression: towards precision medicine (journal article) Nature Reviews Drug Discovery, volume 21, issue 3, pages 224-244 (2022). |
Bag‐1 mediates glucocorticoid receptor trafficking to mitochondria after corticosterone stimulation: Potential role in regulating affective resilience (journal article) Journal of Neurochemistry, volume 158, issue 2, pages 358-372 (2021). |
The American Journal of Geriatric Psychiatry, volume 29, issue 4, pages S127-S128 (2021). |
International Journal of Neuropsychopharmacology, volume 24, issue 1, pages 22-31 (2021). |
Mood Stabilizers (book chapter) In Encyclopedia of Molecular Pharmacology Springer International Publishing (2021) |
Mood Stabilizers (book chapter) In Encyclopedia of Molecular Pharmacology Springer International Publishing (2021) |
Responsible innovation in technology for mental health care (journal article) The Lancet Psychiatry, volume 7, issue 9, pages 728-730 (2020). |
Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent (journal article) The Journal of Clinical Psychiatry, volume 81, issue 3 (2020). |
Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression (journal article) The Journal of Clinical Psychiatry, volume 81, issue 3 (2020). |
ASPI: a public–private partnership to develop treatments for autism (journal article) Nature Reviews Drug Discovery, volume 19, issue 4, pages 219-220 (2020). |
Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3 (journal article) The American Journal of Geriatric Psychiatry, volume 28, issue 2, pages 121-141 (2020). |
Clinical Pharmacology & Therapeutics, volume 107, issue 1, pages 79-81 (2020). |
P.607 Esketamine nasal spray for rapid reduction of major depressive disorder symptoms in patients at imminent risk for suicide: ASPIRE-2 study (journal article) European Neuropsychopharmacology, volume 29 (2019). |
P.323 Esketamine nasal spray for rapid reduction of major depressive disorder symptoms in patients at imminent risk for suicide: aspire-1 study (journal article) European Neuropsychopharmacology, volume 29 (2019). |
P.038 Effect of esketamine nasal spray on cognition in patients with treatment-resistant depression: results from five phase-3 studies (journal article) European Neuropsychopharmacology, volume 29 (2019). |
International Journal of Neuropsychopharmacology, volume 22, issue 10, pages 616-630 (2019). |
Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression (journal article) JAMA Psychiatry, volume 76, issue 9, pages 893- (2019). |
Harnessing digital technology to predict, diagnose, monitor, and develop treatments for brain disorders (journal article) npj Digital Medicine, volume 2, issue 1 (2019). |